Vaccine Roll-out

Karl Turner Excerpts

Thursday 21st January 2021 Commons Chamber

[Matt Hancock]

My hon. Friend is absolutely right that the rate-limiting step is the amount of supply. We are working closely with the two companies, which are doing a terrific job. We talk to them all the time, in trying to ensure that any blockages are removed. They are going as fast as they can in producing the vaccine, whether that is the Oxford vaccine, produced here in this country, or the Pfizer-BioNTech vaccine, produced in Belgium and supplied to us. Everybody is working as fast as we can, and I am delighted that the NHS is champing at the bit for more supply in order to deliver it.

Across Derbyshire there have been more 70,000 vaccinations—70,332, according to the latest data I have, as of 17 January. Derbyshire has vaccinated 65% of its over-80s, which is almost exactly the national average of 67%. Derbyshire is doing a great job; I congratulate those in the NHS in Derbyshire, and thank them for their efforts and their work. There is still a lot further to go, but almost two thirds of Derbyshire’s over-80s have been vaccinated. We have to keep at it and keep working hard to make sure that all the vulnerable are protected, and then move on to the rest of us.

[Karl Turner (Kingston upon Hull East) (Lab) [V]]

After questioning the Prime Minister last week, I am delighted that the first community pharmacies are now taking part in the vaccine roll-out, but just a few hundred of approximately 11,000 community pharmacies just does not seem enough—it is a tiny proportion, leaving vast potential untapped. Will the Secretary of State commit to ensuring that all General Pharmaceutical Council-registered technicians will be allowed to administer vaccines, so that they are available where they are most needed, on every high street, in every community such as mine in east Hull? Witham pharmacy is ready and willing to start vaccinating now—let us get on with it.

[Matt Hancock [V]]

At heart, I agree with the instincts of the hon. Gentleman. The challenge is that we need to do this at scale. As supply is the rate-limiting factor, it is very important that any vaccination site can get enough people through to be able to use the vaccine in time—we do not want to leave stocks in the fridge. Pharmacists are experienced at vaccinating and pharmacy technicians can vaccinate, and they are a very important part of the programme. With pharmacies, we have started with the bigger sites that are able to achieve a higher throughput. It is because supply is the rate-limiting factor that we need to make sure that all supply is used up quickly from the point at which it is distributed. That is why we have taken that approach. I am thrilled that so many pharmacies are now coming on stream; there is lots more to do.